Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 7, 2017; 23(33): 6119-6127
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6119
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6119
Table 3 Results of DNA-PKcs and ERGIC1 from immunohistochemistry
| Group | n | DNA-PKcs | n | ERGIC1 | ||||||
| - | + | ++ | +++ | - | + | ++ | +++ | |||
| Normal | 30 | 12 | 18 | 0 | 0 | 30 | 2 | 2 | 2 | 24 |
| Mild | 30 | 14 | 16 | 0 | 0 | 30 | 2 | 3 | 3 | 22 |
| Moderate | 30 | 5 | 3 | 23 | 0 | 30 | 2 | 3 | 25 | 0 |
| Severe | 30 | 3 | 2 | 25 | 0 | 30 | 5 | 5 | 20 | 0 |
| Cancer | 30 | 0 | 2 | 6 | 22 | 40 | 9 | 27 | 4 | 0 |
- Citation: Wang FR, Wei YC, Han ZJ, He WT, Guan XY, Chen H, Li YM. Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer. World J Gastroenterol 2017; 23(33): 6119-6127
- URL: https://www.wjgnet.com/1007-9327/full/v23/i33/6119.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i33.6119